Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'

Gut. 2017 Aug;66(8):1534-1535. doi: 10.1136/gutjnl-2016-313287. Epub 2016 Nov 24.

Authors

Alex Thompson¹, Stephen Locarnini², Peter Revill²

Affiliations

¹ Department of Gastroenterology, St. Vincent's Hospital, Melbourne, Victoria, Australia.
² Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia.

PMID: 27884921
DOI: 10.1136/gutjnl-2016-313287

No abstract available

Keywords: ANTIVIRAL THERAPY; GENOTYPE; HEPATITIS B; MUTATIONS.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antiviral Agents
DNA, Viral
Genotype
Hepatitis B Surface Antigens*
Hepatitis B e Antigens*
Hepatitis B virus / genetics
Hepatitis B, Chronic
Humans

Substances

Antiviral Agents
DNA, Viral
Hepatitis B Surface Antigens
Hepatitis B e Antigens